Rilhac-Rancon, France

Christophe Carite

This inventor holds 1 USPTO granted patent. Top assignee: Cognis IP Management Gmbh. Active years: 2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Christophe Carite. Retrieved from https://idiyas.com/inventor/christophe-carite-xfuipftb

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Christophe Carite and His Cell-Culture Innovation.

Introduction

Christophe Carite is an inventor associated with Rilhac-Rancon, France. His patent work addresses alternatives to foetal bovine serum in cell-culture media.

Latest Patents

Carite is associated with 1 patent, titled “Use of Esters of Unsaturated, Physiologically Active Fatty Acids as Nutrient Media for Cell Cultures.” The invention describes using esters of unsaturated, physiologically active fatty acids to nourish cell cultures, including as a substitute for foetal bovine serum. The disclosed esters may contain fatty acids with 16 to 24 carbon atoms and 2 to 5 double bonds, combined with a lower alcohol such as ethanol or with a sterol. The patent also describes transesterification products made from natural or synthetic oils, and possible use alongside sterols, phospholipids, or vegetable proteins, or in liposomally encapsulated form.

Career Highlights

The available information associates Carite with Cognis IP Management GmbH. His patent reflects work on nutrient formulations intended to support cell cultivation using physiologically active fatty-acid esters.

Collaborations

Jochen Seifert and Christophe Sicre are identified as Carite’s coworkers. The provided information does not specify their roles in the patent or the nature of their collaboration.

Conclusion

Christophe Carite’s recorded patent focuses on fatty-acid ester-based cell-culture media as a potential alternative to foetal bovine serum.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…